Newsroom
Latest News
- Business25 July 2019
Alvogen’s subsidiary in Taiwan, Lotus Pharmaceuticals collects outstanding company award
- Business11 June 2019
Alvogen announces acquisition to expand CEE business
- Business30 May 2019
Alvogen and Pfenex Announce Acceptance of MAA for PF708
- Business08 April 2019
Alvogen and business partners obtain first European approvals for generic Ulipristal 5mg
- Business01 April 2019
Alvogen settles U.S. Revlimid® patent litigation with Celgene
- Business25 March 2019
Alvogen upgrades its oncology manufacturing facility in Taiwan
- Business20 March 2019
Alvogen confirms cross-investment partnership to strengthen Asia presence
- Business01 March 2019
Alvogen and Pfenex expand development and commercialization collaboration
- Business20 February 2019
Alvogen Launches Generic Equivalent to Suboxone® (buprenorphine/naloxone) Sublingual Film
- Business12 February 2019
Alvogen launches the first generic equivalent to Revlimid™ in Europe
- Business01 February 2019
Kick-off meeting in Iceland
- Business13 December 2018
Robert Wessman becomes the Chairman of Lotus Pharmaceuticals
- People15 October 2018
Robert Wessman wins Leader of the Year award
- Business17 September 2018
Students seek inspiration from Alvogen’s incredible $1bn journey
- Business05 September 2018
Alvogen obtains European approvals for generic Gefitinib
- Charity12 July 2018
Alvogen's World Cup campaign with UNICEF raised over 8 million ISK ($80,000) for children in need
- Business02 July 2018
Alvogen and Prestige Biopharma Announce License and Supply Agreement
- Business25 June 2018
Alvogen announces distribution agreement with Theramex in CEE, Russia and CIS countries
- Business12 June 2018
Alvogen and Pfenex enter into U.S. agreement for commercialization of PF708
- People11 June 2018
Alvogen CEO recognized by European CEO Magazine
- Business24 April 2018
Alvogen obtains European approvals for generic Lenalidomide
